Vast Therapeutics

Vast Therapeutics

Biotechnology, 4222 Emperor BLVD Ste 470, Durham, North Carolina, 27703, United States, 11-50 Employees

vasttherapeutics.com

  • twitter
  • LinkedIn

phone no Phone Number: 91*) 32*****

Who is VAST THERAPEUTICS

Vast is a preclinical airway immunology company focused on breaking the vicious cycle of infection and chronic inflammation in respiratory diseases. The Vast technology platform begins wi...

Read More

map
  • 4222 Emperor BLVD Ste 470, Durham, North Carolina, 27703, United States Headquarters: 4222 Emperor BLVD Ste 470, Durham, North Carolina, 27703, United States
  • 2017 Date Founded: 2017
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 87 | NAICS Code: 54 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from VAST THERAPEUTICS

Vast Therapeutics Org Chart and Mapping

Employees

Tom Coleman

Process Development Engineer

Rebecca McDonald

Director of Bacteriology

John Simons

VP of Product Development

Mona Ahonen

Principal R&D Scientist

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Vast Therapeutics

Answer: Vast Therapeutics's headquarters are located at 4222 Emperor BLVD Ste 470, Durham, North Carolina, 27703, United States

Answer: Vast Therapeutics's phone number is 91*) 32*****

Answer: Vast Therapeutics's official website is https://vasttherapeutics.com

Answer: Vast Therapeutics's revenue is $1 Million to $5 Million

Answer: Vast Therapeutics's SIC: 87

Answer: Vast Therapeutics's NAICS: 54

Answer: Vast Therapeutics has 11-50 employees

Answer: Vast Therapeutics is in Biotechnology

Answer: Vast Therapeutics contact info: Phone number: 91*) 32***** Website: https://vasttherapeutics.com

Answer: Vast is a preclinical airway immunology company focused on breaking the vicious cycle of infection and chronic inflammation in respiratory diseases. The Vast technology platform begins with the unmatched antimicrobial activity of nitric oxide in the form of stable prodrugs. When our new chemical entities are combined with inhalation formulation expertise and proprietary chemistry for delivering drug candidates to the lungs, the result is aerosolized therapies targeting the specific needs of individual patient populations. Nitric oxide is an endogenous molecule that plays a vital role in the natural immune system response to microbial pathogens. Taking cues from human physiology, our nitric oxide based antibiotic alternative compounds are not susceptible to antimicrobial resistance mechanisms common to traditional antibiotics.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access